Sheng Zhang

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

Min Li, Uddalak Bharadwaj, Rongxin Zhang et al. · Molecular Cancer Therapeutics · 2008 · 170 citations · Full text

Tumor Biology, Pancreatic Cancer, Mesothelin Mrna +14

Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway

Xiaoshu Zhou, Rui Zhou, Qianwen Li et al. · Anti-Cancer Drugs · 2019 · 63 citations

MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells

Hua Wang, Xinglan An, Hao Yu et al. · Oncotarget · 2017 · 55 citations · Full text

ATR/Chk1/Smurf1 pathway determines cell fate after DNA damage by controlling RhoB abundance

Meilin Wang, Lei Guo, Qingang Wu et al. · Nature Communications · 2014 · 50 citations · Full text

Rhob Abundance, Genome Instability, Dna Damage +8

Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists

Sheng Zhang, Maj Krumberger, Michael A. Morris et al. · European Journal of Medicinal Chemistry · 2021 · 44 citations · Full text

Medicine, Rational Drug Design, Structure-based Drug Design +9